American College of Rheumatology featuring Medha Barbhaiya, MD, MPH and Doruk Erkan, MD, MPH

An international team of more than 80 collaborators led by Hospital for Special Surgery (HSS) investigators is developing new classification criteria for clinical research of antiphospholipid syndrome (APS), a life-threatening autoimmune clotting dis...

Thanks to the generous support of donors, Hospital for Special Surgery (HSS) has announced the funding of nine grants for projects related to the study of COVID-19. These projects reflect the institution’s expertise in basic, translational and clinic...

The Rheumatologist featuring Doruk Erkan, MD, MPH

Researchers have identified a gut bacterium that can trigger the antiphospholipid antibodies seen in patients with antiphospholipid syndrome (APS), an underrecognized autoimmune disease that can lead to abnormal blood clot formation in arteries and v...

Antiphospholipid syndrome (APS), a systemic autoimmune disease, can be underrecognized, according to a recently published review in the New England Journal of Medicine (2018;378(21):2010-2021). Experts say more patient and physician education is need...

Rheumatic diseases affect women two to four times more often than men. Studying the sex differences in autoimmune conditions has been the focus of the Barbara Volcker Center for Women and Rheumatic Diseases at Hospital for Special Surgery. In a featu...